Using computational techniques in fragment-based drug discovery.
Fragment-based drug discovery has emerged over the past 15 years as an effective lead discovery paradigm that is complementary to traditional high-throughput screening. The starting point for fragment-based drug discovery is the identification of low-molecular weight, typically low-affinity compounds that bind to a target of interest. These fragments can then be elaborated by growing or linking to create compounds with high affinity and selectivity. A wide variety of techniques from the computational chemistry tool chest can be applied in a fragment-based project. The computational tools are equally useful in combination with experimental-binding determination or in a completely in silico design procedure. This chapter will outline these techniques, their utility, and their validation in the design of novel lead compounds.